BG
BSX.PRA
Bollard Group’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-7,226,725
| Closed | -$136M | – | 261 |
|
|
2016
Q1 | $136M | Hold |
7,226,725
| – | – | 10.95% | 2 |
|
|
2015
Q4 | $133M | Hold |
7,226,725
| – | – | 10.97% | 2 |
|
|
2015
Q3 | $119M | Hold |
7,226,725
| – | – | 9.73% | 2 |
|
|
2015
Q2 | $128M | Hold |
7,226,725
| – | – | 9.66% | 2 |
|
|
2015
Q1 | $128M | Hold |
7,226,725
| – | – | 9.55% | 2 |
|
|
2014
Q4 | $95.8M | Hold |
7,226,725
| – | – | 8.45% | 2 |
|
|
2014
Q3 | $85.3M | Hold |
7,226,725
| – | – | 8.06% | 2 |
|
|
2014
Q2 | $92.3M | Hold |
7,226,725
| – | – | 8.92% | 2 |
|
|
2014
Q1 | $97.7M | Hold |
7,226,725
| – | – | 9.88% | 2 |
|
|
2013
Q4 | $86.9M | Hold |
7,226,725
| – | – | 9.58% | 2 |
|
|
2013
Q3 | $84.3M | Buy |
+7,226,725
| New | +$84.3M | 9.92% | 2 |
|